|
Volumn 178, Issue 7, 2002, Pages 363-368
|
Selective lymph node dissection following hyperfractionated accelerated radio-(chemo-)therapy for advanced head and neck cancer
a a a a a a a |
Author keywords
Advanced head and neck cancer; Hyperfractionated accelerated radio (chemo )therapy; Selective lymph node dissection
|
Indexed keywords
FLUOROURACIL;
MITOMYCIN C;
ADVANCED CANCER;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HEAD AND NECK CANCER;
HISTOPATHOLOGY;
HUMAN;
LYMPH NODE DISSECTION;
LYMPH NODE METASTASIS;
MAJOR CLINICAL STUDY;
NECK DISSECTION;
RADIATION DOSE FRACTIONATION;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
COMBINED MODALITY THERAPY;
DOSE FRACTIONATION;
FEMALE;
FLUOROURACIL;
HUMANS;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
MITOMYCIN;
NEOADJUVANT THERAPY;
OTORHINOLARYNGOLOGIC NEOPLASMS;
RADIATION DOSAGE;
SURVIVAL RATE;
|
EID: 0036084349
PISSN: 01797158
EISSN: None
Source Type: Journal
DOI: 10.1007/s00066-002-0965-0 Document Type: Article |
Times cited : (19)
|
References (23)
|